Correlation Between Virax Biolabs and Bionomics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Bionomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Bionomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Bionomics Limited, you can compare the effects of market volatilities on Virax Biolabs and Bionomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Bionomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Bionomics.
Diversification Opportunities for Virax Biolabs and Bionomics
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Virax and Bionomics is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Bionomics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionomics Limited and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Bionomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionomics Limited has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Bionomics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Bionomics
Given the investment horizon of 90 days Virax Biolabs is expected to generate 22.86 times less return on investment than Bionomics. But when comparing it to its historical volatility, Virax Biolabs Group is 3.2 times less risky than Bionomics. It trades about 0.02 of its potential returns per unit of risk. Bionomics Limited is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 3.60 in Bionomics Limited on August 30, 2024 and sell it today you would lose (2.29) from holding Bionomics Limited or give up 63.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 31.11% |
| Values | Daily Returns |
Virax Biolabs Group vs. Bionomics Limited
Performance |
| Timeline |
| Virax Biolabs Group |
| Bionomics Limited |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Virax Biolabs and Bionomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Bionomics
The main advantage of trading using opposite Virax Biolabs and Bionomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Bionomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionomics will offset losses from the drop in Bionomics' long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Bionomics vs. BetterLife Pharma | Bionomics vs. Entheon Biomedical Corp | Bionomics vs. Pharmather Holdings | Bionomics vs. Intelgenx Technologs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |